Needham & Company Remains Bullish on Medidata Solutions (MDSO) Despite Revenue Shortfall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Medidata Reports Full-Year and Fourth Quarter 2015 Results
February 10, 2016 6:31 AM ESTRecord full-year revenue of $392.5 million, a 17% year-over-year increase Record full-year subscription revenue of $336.2 million, a 20% year-over-year increase Record full-year new client wins of 201, a 52% year-over-year increase Record full-year cash flow from operations of $87.0 million, a 41% year-over-year increase Provides 2016 revenue guidance of between $450 and $474 million
NEW YORK--(BUSINESS WIRE)--... More
Celgene Expands Relationship with Medidata in Enterprise Clinical Trial Technology
February 10, 2016 6:30 AM ESTGlobal Biopharma Adds Medidata Clinical Cloud® to Enhance Its Clinical Trial Data Management Capabilities
NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that... More
